Sulfadoxine
Sulfadoxine (also spelled sulphadoxine) is an ultra-long-lasting sulfonamide used in combination with pyrimethamine to treat malaria.[1]
![]() | |
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATCvet code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| NIAID ChemDB | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.017.732 |
| Chemical and physical data | |
| Formula | C12H14N4O4S |
| Molar mass | 310.33 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 190 to 194 °C (374 to 381 °F) |
SMILES
| |
| | |
It is also used to prevent malaria[2] but due to high levels of resistance, this use is becoming less common.[3]
It is also used, usually in combination with other drugs, to treat or prevent various infections in livestock.
Mechanism of action
Sulfadoxine competitively inhibits dihydropteroate synthase, interfering with folate synthesis.
See also
- Sulfadoxine/pyrimethamine
References
- Medical Treatment - Sulphadoxine and Pyrimethamine Archived 2007-12-28 at the Wayback Machine.
- https://www.who.int/malaria/areas/preventive_therapies/pregnancy/en/
- Matondo SI, Temba GS, Kavishe AA, et al. (2014). "High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania". Malar J. 13: 152. doi:10.1186/1475-2875-13-152. PMC 3998221. PMID 24751352.

